Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 3,154 | 2,544 | 1,860 | 2,480 | 1,750 |
| Cost of Goods | 834 | 488 | 337 | 472 | 288 |
| Gross Profit | 2,320 | 2,056 | 1,523 | 2,008 | 1,462 |
| Operating Expenses | 3,830 | 3,710 | 4,106 | 4,566 | 3,573 |
| Operating Income | -1,510 | -1,654 | -2,583 | -2,558 | -2,111 |
| Other Income | 10,280 | 10,170 | 6,550 | 3,766 | 9,619 |
| Pre-tax Income | 8,770 | 8,516 | 3,967 | 1,208 | 7,508 |
| Income Tax | 1,861 | 1,371 | 374 | 749 | 1,461 |
| Net Income Continuous | 6,909 | 7,145 | 3,593 | 459 | 6,047 |
| Net Income | $6,909 | $7,145 | $3,593 | $459 | $6,047 |
| EPS Basic Total Ops | 0.05 | 0.05 | 0.03 | 0.00 | 0.04 |
| EPS Basic Continuous Ops | 0.05 | 0.05 | 0.03 | 0.00 | 0.04 |
| EPS Diluted Total Ops | 0.05 | 0.05 | 0.03 | 0.00 | 0.04 |
| EPS Diluted Continuous Ops | 0.05 | 0.05 | 0.03 | 0.00 | 0.04 |
| EBITDA(a) | $-1,053 | $-1,210 | $-2,044 | $-2,238 | $-1,785 |